Stay updated on Avelumab Adjuvant in Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab Adjuvant in Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab Adjuvant in Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A new publication entry from Clin Cancer Res (2026 Jul 17) was added to Publications, describing tumor infiltrating lymphocytes as a predictor of adjuvant avelumab efficacy, with notes that entries are automatically filled from PubMed and the revision updated to v3.6.4.
    Difference
    0.2%
    Check dated 2026-07-26T22:38:29.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3. This indicates an update was applied to the page, reflecting its version history rather than user-facing content.
    Difference
    0.0%
    Check dated 2026-07-05T04:38:03.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.2, updating the previous revision v3.6.0.
    Difference
    0.0%
    Check dated 2026-06-27T23:16:10.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page now displays 'No longer looking for participants', signaling that the study is no longer enrolling. Additionally, new help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment heading formatting was adjusted, and the revision tag was updated to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-13T16:28:35.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, signaling a new build of the page. This change represents a behind-the-scenes update and does not alter the study details or visible content.
    Difference
    0.0%
    Check dated 2026-06-06T08:55:36.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    The study location entry Macerata, Italy was replaced with Province of Macerata, Italy, changing the geographic scope of the site listing; the document revision was updated from v3.5.3 to v3.5.4.
    Difference
    0.7%
    Check dated 2026-05-14T22:21:03.000Z thumbnail image

Stay in the know with updates to Avelumab Adjuvant in Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab Adjuvant in Triple-Negative Breast Cancer Clinical Trial page.